Cargando…

An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses

Detalles Bibliográficos
Autores principales:	Prokopez, Cintia R., Vallejos, Miguel, Lopredo, Lorena S., Sfriso, Luciano E., Chiapella, Luciana C., Arce, Claudio, Corral, Ricardo M., Cuesta, Manuel J., Farinola, Romina, Alomo, Martín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220941/ https://www.ncbi.nlm.nih.gov/pubmed/34215466 http://dx.doi.org/10.1016/j.schres.2021.06.019

Ejemplares similares

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
por: Prokopez, Cintia R., et al.
Publicado: (2022)

T184. THE ROLE OF ADVERSE CHILDHOOD EXPERIENCES IN THE DEVELOPMENT OF A MORE SEVERE TYPE OF SCHIZOPHRENIA
por: Prokopez, Cintia, et al.
Publicado: (2020)

Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
por: Younas, Mediha, et al.
Publicado: (2016)

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness
por: Llorca, Pierre Michel, et al.
Publicado: (2013)

Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021)

Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2023)

Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice
por: Jakobs, Kirsti M., et al.
Publicado: (2020)

Diabetes Prevalence and Risk Factors in Patients With Chronic Mental Illness on Second-Generation Antipsychotics
por: Sahay, Priya, et al.
Publicado: (2021)

Optimization of antipsychotic use in the elderly with severe mental illness; a review of three cases.
por: Izquierdo De La Puente, A., et al.
Publicado: (2023)

Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness
por: Forma, Felicia, et al.
Publicado: (2020)

Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications
por: Caldara, Marina, et al.
Publicado: (2021)

Using A Pharmacy-Based Intervention To Improve Antipsychotic Adherence Among Patients With Serious Mental Illness
por: Valenstein, Marcia, et al.
Publicado: (2011)

Can incentives improve antipsychotic adherence in major mental illness? A mixed-methods systematic review
por: Hodson, Nathan, et al.
Publicado: (2022)

Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes
por: Aakre, Jennifer M, et al.
Publicado: (2012)

Metabolic Syndrome in Patients with Severe Mental Illness Undergoing Psychiatric Rehabilitation Receiving High Dose Antipsychotic Medication
por: Ravindranath, Bapu V.
Publicado: (2012)

Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study
por: Ma, Qiuyue, et al.
Publicado: (2021)

Effectiveness of Antipsychotics in Reducing Suicidal Ideation: Possible Physiologic Mechanisms
por: Hassan, Ahmed, et al.
Publicado: (2021)

Switching antipsychotics to support the physical health of people with severe mental illness: a qualitative study of healthcare professionals’ perspectives
por: Nash, Annabel, et al.
Publicado: (2021)

Mental illnesses among COVID-19 patients: Possible immunological underpinnings
por: Kar, Sujita Kumar, et al.
Publicado: (2020)

Diabetic control and atypical antipsychotics: a case report
por: Gaston, Romina Lopez, et al.
Publicado: (2008)

Antipsychotic monitoring in dementia: quality of completion of antipsychotic monitoring forms in an older adult mental health service
por: Anderson, Helen, et al.
Publicado: (2022)

17.4 POSSIBLE MECHANISMS INVOLVED IN THE ANTIPSYCHOTIC EFFECTS OF CANNABIDIOL (CBD)
por: Crippa, Jose Alexandre, et al.
Publicado: (2018)

Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma
por: Vallée, Alexandre, et al.
Publicado: (2021)

Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data
por: Stockbridge, Erica L., et al.
Publicado: (2021)

Hippocampal Shape and Volume Changes with Antipsychotics in Early Stage Psychotic Illness
por: Mamah, Daniel, et al.
Publicado: (2012)

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness
por: Velligan, Dawn I, et al.
Publicado: (2017)

The Use of Long-Acting Injectable Antipsychotics (LAI) in the Serious Mental Illness (SMI) Patients Enrolled in an Assertive Community Treatment (ACT) Program
por: Yee, Maria Ruiza, et al.
Publicado: (2021)

Perspectives of patients and healthcare professionals on metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness: A meta-synthesis
por: Poojari, Pooja Gopal, et al.
Publicado: (2023)

Magic Bullets for Mental Disorders: The Emergence of the Concept of an “Antipsychotic” Drug
por: Moncrieff, Joanna
Publicado: (2013)

Perceptions and knowledge of antipsychotics among mental health professionals and patients
por: Cahling, Lindah, et al.
Publicado: (2017)

Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation
por: Cooper, Ruth E., et al.
Publicado: (2019)

The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects
por: Hashimoto, Naoki, et al.
Publicado: (2017)

REalist Synthesis Of non-pharmacologicaL interVEntions for antipsychotic-induced weight gain (RESOLVE) in people living with severe mental illness (SMI)
por: Maidment, Ian D., et al.
Publicado: (2022)

Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
por: Jakobs, Kirsti, et al.
Publicado: (2022)

An Exploration of the Possibilities of Current Mental Health Services to Tackle Transgenerational Effects of Parental Mental Illnesses on Offspring Adjustment in Lithuania
por: Lesinskiene, Sigita
Publicado: (2021)

The relationship between quality of life and physical fitness in people with severe mental illness
por: Perez-Cruzado, D., et al.
Publicado: (2018)

S19. THE ROLE OF ACE AS POSSIBLE BIOMARKER FOR TREATMENT RESISTANCE TO ANTIPSYCHOTICS IN FIRST EPISODE OF PSYCHOSIS
por: Luisa, Longo, et al.
Publicado: (2020)

Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview
por: Borovcanin, Milica M, et al.
Publicado: (2021)

Clinicians’ adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness
por: Manchia, Mirko, et al.
Publicado: (2017)

Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study
por: Mitchell, Alex J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hspm8n5dihphedk2k2ffrjdkeb